A Biotech Slump Is Emptying Labs and Threatening Research on New Drugs
Sangamo Therapeutics Inc.’s cost cuts didn’t hurt just the roughly 162 US workers who lost their jobs this
2023-11-22 19:51
Asset manager GMO's first ETF will focus on 'quality' companies
By Suzanne McGee GMO LLC, the asset management firm co-founded by veteran investor Jeremy Grantham, will launch its
2023-11-14 04:22